Company History

Year of foundation of the SPEY

2001

2004

Production of the first products

Production of the company's first products on the production lines of European partners.

2006

Expanding the geographical presence

Opening of representative offices in Kazakhstan, Kyrgyzstan, Turkmenistan and Tajikistan.

2008

First registration certificates

Obtaining the first registration certificates in the countries of the company's presence.

2010

Start of sales

Start of sales of SPEY drugs in Kazakhstan and Kyrgyzstan.

2012

The emergence of a representative office in India

Opening of a regional office in India.

2013

Entry to the markets of Georgia and Armenia

More than 50 registered names of drugs in the countries of presence.

2014

Strengthening the position

Strengthening the position in Eastern Europe.

Opening of an office in Skopje, Macedonia.

2015

Registration of the SPEY company in the Russian Federation

Registration of the SPEY company in the Russian Federation and the beginning of registration of drugs.

2016

Expanding the geographical presence

Expanding its geographical presence in Southeast Asian countries such as Vietnam, the Philippines, Myanmar and Cambodia.

2017

Start of sales in Uzbekistan

Start of sales of SPEY drugs in Uzbekistan.

Achieving an annual turnover of 85 million US dollars.

2019

Expanding the geographical presence in Latin America

Entry to the Dominican Republic market.

300 registered names of drugs in the countries of presence.

2020

Registration in Ukraine

The beginning of the registration process of SPEY drugs in Ukraine.

Present time

SPEY is an international pharmaceutical company founded in 2001.

Our company is engaged in the development and marketing of high-quality and innovative pharmaceutical products for the needs of a wide range of therapeutic areas. All products are manufactured at production facilities equipped with advanced technology and approved by the world quality standards of the World Health Organization (WHO) and Good Manufacturing Practice (GMP).

In a short period of time, SPEY has become one of the most dynamically developing global pharmaceutical companies, with business connections in more than 20 countries around the world. Among them: Russia, Armenia, Azerbaijan, Georgia, CIS countries (Kazakhstan, Tajikistan, Uzbekistan, Turkmenistan and Kyrgyzstan), India, Nepal, Mongolia, Southeast Asian countries (Philippines, Vietnam, Cambodia, Myanmar) and markets in Africa and Latin America.

In today's society, SPEY strives to improve the quality of life of people with effective and affordable medicines. We are sure that successful projects are born from good ideas and their high-quality execution together with great talent.

About